1. Home
  2. WOR vs HRMY Comparison

WOR vs HRMY Comparison

Compare WOR & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Enterprises Inc.

WOR

Worthington Enterprises Inc.

N/A

Current Price

$60.84

Market Cap

3.0B

ML Signal

N/A

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

N/A

Current Price

$40.06

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WOR
HRMY
Founded
1955
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.4B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
WOR
HRMY
Price
$60.84
$40.06
Analyst Decision
Hold
Buy
Analyst Count
2
9
Target Price
★ $59.50
$44.11
AVG Volume (30 Days)
409.3K
★ 861.2K
Earning Date
03-24-2026
05-07-2026
Dividend Yield
★ 1.41%
N/A
EPS Growth
★ 63.54
7.97
EPS
★ 3.14
1.84
Revenue
★ $1,381,292,000.00
$868,453,000.00
Revenue This Year
$22.21
$19.75
Revenue Next Year
$6.03
$12.88
P/E Ratio
★ $19.39
$21.74
Revenue Growth
19.72
★ 21.51
52 Week Low
$45.01
$25.52
52 Week High
$67.54
$43.49

Technical Indicators

Market Signals
Indicator
WOR
HRMY
Relative Strength Index (RSI) 56.18 45.95
Support Level $52.34 $37.30
Resistance Level $63.13 $43.38
Average True Range (ATR) 2.67 1.16
MACD 0.28 -0.37
Stochastic Oscillator 49.35 14.46

Price Performance

Historical Comparison
WOR
HRMY

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: